Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Shares Outstanding (Weighted Average): 2016-2020

Historic Shares Outstanding (Weighted Average) for Monopar Therapeutics (MNPR) over the last 4 years, with Sep 2020 value amounting to $2.1 million.

  • Monopar Therapeutics' Shares Outstanding (Weighted Average) rose 15.55% to $2.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $2.1 million, marking a year-over-year increase of 15.55%. This contributed to the annual value of $6.1 million for FY2024, which is 105.58% up from last year.
  • According to the latest figures from Q3 2020, Monopar Therapeutics' Shares Outstanding (Weighted Average) is $2.1 million, which was up 0.96% from $2.1 million recorded in Q2 2020.
  • Monopar Therapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $2.1 million for Q3 2020, and its period low was $1.9 million during Q4 2016.
  • In the last 3 years, Monopar Therapeutics' Shares Outstanding (Weighted Average) had a median value of $1.9 million in 2019 and averaged $2.0 million.
  • Data for Monopar Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY climbed of 15.55% (in 2020) over the last 5 years.
  • Monopar Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $1.9 million in 2016, then remained steady at $1.9 million in 2017, then remained steady at $1.9 million in 2018, then increased by 12.16% to $2.1 million in 2019, then rose by 15.55% to $2.1 million in 2020.
  • Its last three reported values are $2.1 million in Q3 2020, $2.1 million for Q2 2020, and $2.1 million during Q1 2020.